ABOUT ALEMBIC ENZICTRA

ENZICTRA TABLET contains Bromelain, Papain, Rutoside, and Trypsin which belongs to the group of medicines called Plant derivatives, and Proteolytic enzyme. It is used in the treatment of inflammation associated with conditions like post-operative (wound after any surgical procedures which is characterised by pain and redness), and traumatic or injury conditions, rheumatic & degenerative conditions like osteoarthritis, and osteoporosis, strain, sprains, and sports injury, low back pain, and spondylopathies. Arthritis is the tenderness or swelling of one or more joints characterized by pain, stiffness, and reduced movements. ENZICTRA TABLET is not recommended for use in patients having liver, and kidney problems and any scheduled surgery. ENZICTRA TABLET should be used with caution in patients having asthma. ENZICTRA TABLET is not recommended for use during pregnancy and it should be used with caution in breastfeeding women. ENZICTRA TABLET is generally not recommended for use in children who are at the age of breastfeeding. The safety and efficacy of ENZICTRA TABLET have not been establishes in children below 18 years of age. The most common side effects of taking ENZICTRA TABLET are a burning sensation and constipation. Consult your doctor for advice if any of these worsen or don’t improve.